The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Abstract
BACKGROUND AND AIMS: A general dysbiosis of the intestinal microbiota has been established in patients with Crohn's disease (CD), but a systematic characterisation of this dysbiosis is lacking. Therefore the composition of the predominant faecal microbiota of patients with CD was studied in comparison with the predominant composition in unaffected controls. Whether dysbiosis is present in relatives of patients CD was also examined. METHODS: Focusing on families with at least three members affected with CD, faecal samples of 68 patients with CD, 84 of their unaffected relatives and 55 matched controls were subjected to community fingerprinting of the predominant microbiota using denaturing gradient gel electrophoresis (DGGE). To analyse the DGGE profiles, BioNumerics software and non-parametric statistical analyses (SPSS V.17.0) were used. Observed differences in the predominant microbiota were subsequently confirmed and quantified with real-time PCR. RESULTS: Five bacterial species characterised dysbiosis in CD, namely a decrease in Dialister invisus (p=0.04), an uncharacterised species of Clostridium cluster XIVa (p = 0.03), Faecalibacterium prausnitzii (p < 1.3 × 10⁻⁵) and Bifidobacterium adolescentis (p = 5.4 × 10⁻⁶), and an increase in Ruminococcus gnavus (p = 2.1 × 10⁻⁷). Unaffected relatives of patients with CD had less Collinsella aerofaciens (p = 0.004) and a member of the Escherichia coli-Shigella group (p = 0.01) and more Ruminococcus torques (p = 0.02) in their predominant microbiota as compared with healthy subjects. CONCLUSION: Unaffected relatives of patients with CD have a different composition of their microbiota compared with healthy controls. This dysbiosis is not characterised by lack of butyrate producing-bacteria as observed in CD but suggests a role for microorganisms with mucin degradation capacity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although dysbiosis is associated with chronic inflammation and production of carcinogenic metabolites, 175, 176 there is limited evidence to support a direct link between specific intestinal bacteria, their virulence factors, and sporadic CRC.”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [175]
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Hampe, J., Franke, A., Rosenstiel, P. C., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., Vega, F. M. D. L., Briggs, J. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,948
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. J. R., Soars, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,175
D’Haens, G., Geboes, K., Peeters, M., Baert, F., PENNINCKX, F. M., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 866
Self-citationPresence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
Darfeuille–Michaud, A., Neut, C., Barnich, N., Lederman, E., Martino, P. D., Desreumaux, P., Gambiez, L. P., Joly, B., Cortot, A., & Colombel, J.-F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70019-8 · Cited by 859
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M. I., Vantrappen, G. R., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 758
Self-citationMartin, H., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M. K., Singh, R., Englyst, H. N., Williams, H. F., & Rhodes, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.054 · Cited by 719
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. M. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-24180-9_2 · Cited by 666
Franchimont, D. P., Vermeire, S., Housni, H. E., Pierik, M. J., Steen, K. V., Gustot, T., Quertinmont, E., Abramowicz, M., Gossum, A. V., Devière, J., et al. (2004) · Gut · doi:10.1136/gut.2003.030205 · Cited by 596
Self-citationDiversity of the human gastrointestinal tract microbiota revisited
Rajilić‐Stojanović, M., Smidt, H., & De Vos, W. M. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01369.x · Cited by 559
The Host Genotype Affects the Bacterial Community in the Human Gastronintestinal Tract
Zoetendal, A. D. L. A. E. G. (2001) · Microbial Ecology in Health and Disease · doi:10.1080/089106001750462669 · Cited by 558
Louis, P., Duncan, S. H., McCrae, S. I., Millar, J., Jackson, M. S., & Flint, H. J. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.7.2099-2106.2004 · Cited by 517
Assembly of the human intestinal microbiota
Dethlefsen, L., Eckburg, P. B., Bik, E. M., & Relman, D. A. (2006) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2006.06.013 · Cited by 509
Molecular analysis of the gut microbiota of identical twins with Crohn's disease
Dicksved, J., Halfvarson, J., Rosenquist, M., Järnerot, G., Tysk, C., Apajalahti, J., Engstrand, L. G., & Jansson, J. K. (2008) · The ISME Journal · doi:10.1038/ismej.2008.37 · Cited by 459
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Specificities of the fecal microbiota in inflammatory bowel disease
Sokol, H., Seksik, P., Rigottier‐Gois, L., Lay, C., Lepage, P., Podglajen, I., Marteau, P. R., & Dore, J. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000200323.38139.c6 · Cited by 447
Scanlan, P. D., Shanahan, F., O'Mahony, C., & Marchesi, J. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00312-06 · Cited by 330
Martínez-Medina, M., Aldeguer, X., Gónzalez‐Huix, F., Acero, D., & Garcia-Gil, L. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235828.09305.0c · Cited by 263
Invasive Escherichia coli are a feature of Crohn's disease
Sasaki, M., Sitaraman, S. V., Babbin, B. A., Gerner‐Smidt, P., Ribot, E. M., Garrett, N. A., Alpern, J. A., Akyildiz, A., Theiss, A. L., Nusrat, A., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700661 · Cited by 243
Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease
Favier, C., Neut, C., Mizon, C., Cortot, A., Colombel, J., & Mizon, J. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018876400528 · Cited by 219
Vanhoutte, T., Huys, G. R. B., Brandt, E. D., & Swings, J. (2004) · FEMS Microbiology Ecology · doi:10.1016/j.femsec.2004.03.001 · Cited by 215
Self-citationCandida albicans Colonization and ASCA in Familial Crohn's Disease
Standaert‐Vitse, A., Sendid, B., Joossens, M., François, N., Khoury, P. V.-E., Branche, J., Kruiningen, H. J. V., Jouault, T., Rutgeerts, P. J., Gower‐Rousseau, C., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.225 · Cited by 214
Self-citationStewart, J. A., CHADWICK, V. S., & Murray, A. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46189-0 · Cited by 208
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
Seksik, P., Sokol, H., Lepage, P., Vasquez, N., Manichanh, C., Mangin, I., Pochart, P., Dore, J. M., & Marteau, P. R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03053.x · Cited by 166
Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase
Colina, A. R., Aumont, F., Deslauriers, N., Belhumeur, P., & de Repentigny, L. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4514-4519.1996 · Cited by 161
Beaud, D., Tailliez, P., & Anba-Mondoloni, J. (2005) · Microbiology · doi:10.1099/mic.0.27712-0 · Cited by 160
Russell, R. K., & Satsangi, J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.12.006 · Cited by 140
Kageyama, A., Benno, Y., & Nakase, T. (1999) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/00207713-49-2-557 · Cited by 131
Gut flora and inflammatory bowel disease
Marteau, P. R., Lepage, P., Mangin, I., Suau, A., Dore, J. M., Pochart, P., & Seksik, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02062.x · Cited by 128
van de Merwe, J. P., Stegeman, J. H., & Hazenberg, M. P. (1983) · Antonie van Leeuwenhoek · doi:10.1007/bf00393669 · Cited by 118
van de Merwe, J. P., Schröder, A., Wensinck, F., & Hazenberg, M. P. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809090179 · Cited by 101
Ribosomal DNA Sequence Analysis of Mucosa-Associated Bacteria in Crohn’s Disease
Prindiville, T., Cantrell, M. C., & Wilson, K. H. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200411000-00017 · Cited by 95
Dialister invisus sp. nov., isolated from the human oral cavity
Downes, J. (2003) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.02640-0 · Cited by 91
Environmental Factors in Familial Crohnʼs Disease in Belgium
Kruiningen, H. J. V., Joossens, M., Vermeire, S., Joossens, S. B. A., Debeugny, S., Gower‐Rousseau, C., Cortot, A., Colombel, J., Rutgeerts, P. J., & VLIETINCK, R. F. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000158536.31557.90 · Cited by 77
Self-citationGafan, G. P., & Spratt, D. A. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.048 · Cited by 74
Andoh, A., Tsujikawa, T., Sasaki, M., Mitsuyama, K., Suzuki, Y., Matsui, T., Matsumoto, T., Benno, Y., & Fujiyama, Y. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03860.x · Cited by 64
Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohnʼs disease
Joossens, M., Steen, K. V., Branche, J., Sendid, B., Rutgeerts, P. J., Vasseur, F., Poulain, D., Broly, F., Colombel, J., Vermeire, S., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20985 · Cited by 42
Self-citationScanlan, P. D., Shanahan, F., O’Mahony, C., & Marchesi, J. R. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00398-07 · Cited by 25
van de Merwe, J. P., & Stegeman, J. H. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150823 · Cited by 22
Huys, G. R. B., Vanhoutte, T., & Vandamme, P. A. R. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/597603 · Cited by 20
Self-citationD’Haens, G., Geboes, K. J., Peeters, M., Baert, F., PENNINCKX, F. M., & Rutgeerts, P. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199804000-00022 · Cited by 19
Self-citationVanhoutte, T. (2004) · FEMS Microbiology Ecology · doi:10.1016/s0168-6496(04)00075-3 · Cited by 9
Flagged first, then by citations
Cited by
Sorted by citations
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315
Metadata
- Authors
- Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Ghent University (BE)
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-01-05
- Volume
- 60
- Issue
- 5
- Pages
- 631-637
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2139327060
- Semantic Scholar
- 3c76b951197740ae02ffa2ef816767ede9de1b85
- Cited by
- 1,063
- References
- 47
- Citations by year
- 2026: 30 · 2025: 67 · 2024: 88 · 2023: 91 · 2022: 73 · 2021: 103 · 2020: 95 · 2019: 81 · 2018: 65 · 2017: 60 · 2016: 74 · 2015: 56 · 2014: 68 · 2013: 57 · 2012: 34
- FWCI
- 23.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Keywords
- Crohn's disease, fecal microbiota, dysbiosis, gut microbiota composition, unaffected relatives, Dialister invisus, Faecalibacterium prausnitzii, Bifidobacterium adolescentis, Ruminococcus gnavus, Ruminococcus torques, Collinsella aerofaciens, Clostridium cluster XIVa, mucin degradation, butyrate-producing bacteria, familial aggregation
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacteria, Crohn Disease, DNA, Bacterial, Feces, Female, Humans, Male, Middle Aged, Symbiosis, Case-Control Studies, Reverse Transcriptase Polymerase Chain Reaction, Metagenome, Young Adult, Denaturing Gradient Gel Electrophoresis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
